Biomolecular Interaction Analysis System "Octet Systems"

The Octet system has a proven track record not only in kinetics analysis but also in the specific quantitative measurement of biomolecules based on Binding Rate. Compared to ELISA and HPLC, it allows for simple, quick, and highly accurate quantitative measurements. Octet quantitative analysis for screening expression libraries, optimizing culture conditions, and checking purifications contributes to the simplification of processes in biopharmaceutical development, enabling the acceleration of the entire development flow. If you wish to view the On-Demand Webinar, please fill in your customer information from the "Details & Application" link below. After completing your application, the On-Demand viewing link will be displayed on the screen. The webinar presentation slides can be downloaded from the related catalog below.

Zaltrius has launched the Octet R series, a modular label-free real-time biomolecular interaction analysis system. It can be upgraded to meet future throughput demands, which helps to reduce initial costs. The Octet series employs a bio-layer interferometry method that does not require microfluidics, making maintenance easy, improving lab productivity, reducing costs, and shortening experimental timelines.

The World Health Organization (WHO) recognized on March 11, 2020, that the novel coronavirus (COVID-19) infection had reached a pandemic level. Currently, there is a demand for the acceleration of research on treatments and vaccine development for this infection. To expedite the development of therapeutics and vaccines, advanced analytical techniques are crucial for rapid screening of many candidates and for determining the most promising candidates. The Octet system enables real-time assays of biomolecular interactions using BLI technology and allows for high-throughput screening and evaluation of candidates through simultaneous measurement of multiple samples. As a result, data from the Octet system has been featured in many papers that bring breakthroughs related to the biological research of COVID-19 and vaccine and therapeutic development. ■ Ended (2020/10/20) 【Update Information】 If you wish to view the webinar, please fill in your customer information from the "Details & Application" link below. After completing your application, an On-Demand viewing link will be displayed on the screen. The webinar presentation slides can be downloaded from the related catalog below.

One of the most important steps in the antibody development workflow is how to efficiently screen excellent antibodies from a large number of antibodies produced using immunological methods and phage display methods. The conventional ELISA method, which analyzes based on affinity, cannot distinguish between clones that express low-affinity antibodies at high levels and clones that express high-affinity antibodies at low levels; therefore, methods that analyze based on kinetic information become effective. The Octet system enables the identification of clones that produce high-affinity antibodies, which is considered difficult with the ELISA method. Obtaining kinetic information at an earlier stage in the development of antibody drugs and diagnostic agents can lead to the simplification of subsequent processes and accelerate the entire development flow. ■ Completed (2020/11/17) 【Update Information】 If you wish to view the webinar, please fill out your customer information from the "Details & Application" link below. After completing your application, an On-Demand viewing link will be displayed on the screen. The webinar presentation slides can be downloaded from the related catalog below.